Spruce Biosciences, Inc. (SPRB) Operating income 2019–2025
Spruce Biosciences, Inc. (SPRB) annual operating income history from SEC filings — each fiscal year as reported.
-$36.5MFY2025 · since FY2019: -$13.1M → -$36.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$36.5M | +35.0% |
| FY2024 | -$56.2M | -8.0% |
| FY2023 | -$52.0M | -10.0% |
| FY2022 | -$47.3M | -12.4% |
| FY2021 | -$42.1M | -43.0% |
| FY2020 | -$29.4M | -124.4% |
| FY2019 | -$13.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SPRB financial trends
SPRB RevenueSPRB Net incomeSPRB Net marginSPRB Gross profitSPRB Gross marginSPRB Operating marginSPRB Operating cash flowSPRB Free cash flowSPRB Capital expendituresSPRB Return on equitySPRB Stock buybacksSPRB Dividends paidSPRB Total assetsSPRB Total liabilitiesSPRB Shareholders’ equitySPRB overview →